Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEn+ Group S Regulatory News (ENPL)

  • This share is currently suspended. It was suspended at a price of 9.30

Share Price Information for En+ Group S (ENPL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.30
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.30
ENPL Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EN+ applies for listing of ordinary shares on MOEX

13 Feb 2020 17:19

RNS Number : 9769C
EN+ Group Intnl PJSC
13 February 2020
 

EN+ GROUP IPJSC applies for listing of ordinary shares on MOEX

13 February 2020 - EN+ GROUP IPJSC (the "Company") (LSE: ENPL; MOEX: ENPL), further to the announcement of 9 July 2019 in which the Company indicated its intention to create a diversified platform for investors in equity instruments and to increase the Company's access to capital markets, announces that it continues to pursue a listing of its ordinary shares ("Ordinary Shares") on the Moscow Exchange (the "MOEX Listing") and delisting of its Regulation S global depositary receipts (ISIN: US29355E2081) ("GDRs") from the Moscow Exchange.

As part of the MOEX Listing process, the Company has fulfilled the key documentary steps and today filed an application with MOEX to achieve the listing of its Ordinary Shares. MOEX has a review period of up to 20 business days to grant the MOEX Listing.

The Company and MOEX have agreed that the GDRs will be delisted from MOEX upon expiration of two months from the MOEX Listing. Thus, during the transition period of two months, two equity instruments (GDRs and Ordinary Shares) will continue to be traded on MOEX. The Company will separately announce the date of delisting of GDRs from MOEX following the approval of the MOEX Listing and of the commencement of trading in the Ordinary Shares.

In view of this, the Company would like to provide the following information for holders of its Ordinary Shares or GDRs:

1. If you are an existing holder of the Company's Ordinary Shares (ISIN: RU000A100K72) and would like to take preparatory steps to trade such Ordinary Shares on the Moscow Exchange ("MOEX") following completion of the MOEX Listing, please contact Joint Stock Company "Interregional Registration Center" at info@mrz.ru directly for documentation requirements and additional details.

 

2. If you are an existing holder of the Company's Ordinary Shares (ISIN: RU000A100K72) and would like to convert such Ordinary Shares into GDRs (subject to the maximum number of GDRs being 159,712,224 GDRs pursuant to Federal Law No. 290-FZ "On International Companies and International Funds" (as disclosed on 9 July 2019)), please refer to the information published by the Company on 29 July 2019, available here (in English and Russian):

https://www.enplusgroup.com/upload/Information%20sheet%20GDR%20conversion.pdf.

 

3. If you are an existing holder of the Company's Regulation S GDRs (ISIN: US29355E2081) listed on the MOEX and would like to continue trading such GDRs on the London Stock Exchange following their delisting from the MOEX, please contact your broker for further advice on the appropriate action to take.

 

4. If you are an existing holder of the Company's Regulation S GDRs (ISIN: US29355E2081) listed on the MOEX and would like to convert such GDRs into Ordinary Shares, please refer to the process outlined here:

 

https://www.sberbank.ru/common/img/uploaded/dp/adr_cancellation.pdf (English)

https://www.sberbank.ru/common/img/uploaded/dp/pogashenie_raspisok.pdf (Russian)

 

Investors and prospective investors are advised to consult with their legal, financial, tax and strategic advisers regarding the MOEX Listing. The Company will provide further updates on the above-discussed matters as soon as possible.

For further information, please contact:

For media:

For investors:

Tel: +7 495 642 79 37

Email: press-center@enplus.ru

Hudson Sandler LLP 

Andrew Leach

Tel: +44 (0) 20 7796 4133

Email : ENplus@hudsonsandler.com

 

Tel: +7 (495) 642 7937

Email: ir@enplus.ru

Citi Depositary Receipt Services

Tel: +1-212-723-5435

Email: citiadr@citi.com

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Group's business, results of operations, financial position, liquidity, prospects, growth or strategies. Forward-looking statements speak only as of the date they are made.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURTJMRTMTBBBRM
Date   Source Headline
23rd Aug 20192:00 pmRNSEN+ GROUP UPDATED 1H AND 2Q 2019 FINANCIAL RESULTS
22nd Aug 20193:00 pmRNSBoard meeting to consider updates to fin. results
16th Aug 20197:00 amRNSEN+ GROUP 1H AND 2Q 2019 FINANCIAL RESULTS
30th Jul 201912:08 pmRNSSecond Price Monitoring Extn
30th Jul 201912:02 pmRNSPrice Monitoring Extension
29th Jul 20194:11 pmRNSFurther re conversion of shares into GDRs
22nd Jul 201912:07 pmRNSSecond Price Monitoring Extn
22nd Jul 201912:02 pmRNSPrice Monitoring Extension
17th Jul 20195:00 pmRNSFITCH ASSIGNS EN+ GROUP IPJSC 'BB-' CREDIT RATING
9th Jul 20195:15 pmRNSFurther re EN+ continuance into Russia
31st May 20197:00 amRNSEN+ GROUP 1Q 2019 FINANCIAL RESULTS
29th May 20199:40 amRNSResult of AGM 2019
30th Apr 20197:00 amRNSStatement re EN+ GROUP 1Q 2019 Operational results
29th Apr 20196:02 pmRNSCirc re. AGM 2019
29th Apr 20197:00 amRNSEN+ Annual Report 2018
25th Apr 20194:56 pmRNSEn+ Group announces Director's resignation
12th Apr 201912:07 pmRNSSecond Price Monitoring Extn
12th Apr 201912:02 pmRNSPrice Monitoring Extension
28th Mar 201911:10 amRNSEN+ GROUP FY 2018 Financial results
14th Mar 201912:07 pmRNSSecond Price Monitoring Extn
14th Mar 201912:02 pmRNSPrice Monitoring Extension
22nd Feb 201912:58 pmRNSEN+ Instructions re conversion of shares into GDRs
14th Feb 20195:06 pmRNSEN+ appointments to the Board committees
8th Feb 20194:59 pmRNSEN+ board of directors results
8th Feb 20197:00 amRNSStatement re En+ Group 4Q2018 Operational results
1st Feb 20197:01 amRNSFurther re EN+ agreement with cert. Glencore subs.
30th Jan 20198:09 amRNSEN+ GDRs clearing and settlement normalised
28th Jan 20197:05 amRNSFurther re independent trustee arrangements
28th Jan 20197:00 amRNSEn+ Board members resignations
28th Jan 20197:00 amRNSEN+ announces new Board members
28th Jan 20197:00 amRNSEN+ agreement with cert. subsidiaries of Glencore
28th Jan 20197:00 amRNSEn+ removal from OFAC's SDN List
18th Jan 20197:00 amRNSEn+ response to press speculation
17th Jan 20195:52 pmRNSDoc re. extension of OFAC licenses
20th Dec 201811:29 amRNSResults of General Meeting
20th Dec 20187:00 amRNSDoc re. OFAC notification to the U.S.Congress
30th Nov 20188:35 amRNSNotice of GM
16th Nov 20188:13 amRNS9M and 3Q 2018 financial and operational results
2nd Nov 20184:40 pmRNSFurther re Barker Plan and Redomiciliation
2nd Nov 20184:34 pmRNSStatement re executive appointments
15th Oct 20187:00 amRNSDoc re. (Extension of licenses: 13E, 14B and 16B)
24th Sep 20189:00 amRNSExtension of General Licenses 13D,14A and 16A
15th Aug 201810:48 amRNS1H and 2Q 2018 FINANCIAL AND OPERATIONAL RESULTS
26th Jul 20182:04 pmRNSEN+ GROUP PLC AGM RESULTS 2018
6th Jul 20189:40 amRNSEN+ ANNOUNCES ITS 2018 ANNUAL GENERAL MEETING
27th Jun 20184:08 pmRNSEN+ ANNOUNCES CHANGES TO THE BOARD OF DIRECTORS
5th Jun 20181:51 pmRNSOFAC EXTENDS DEADLINE FOR ACTIVITIES
4th Jun 20187:08 amRNSEN+ GROUP ANNOUNCES DIRECTOR'S RESIGNATION
1st Jun 20184:55 pmRNSDoc re. OFAC EXTENDS GENERAL LICENSE NO. 13B
18th May 20182:55 pmRNS1Q 2018 FINANCIAL AND OPERATIONAL RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.